FELICIA MCKNIGHT: Open Payments
NPI 1942785019 · DARLINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 37 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $325 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $165 |
| AstraZeneca Pharmaceuticals LP | 5 | $164 |
| Corcept Therapeutics | 4 | $86 |
| Novo Nordisk Inc | 4 | $76 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| ABBVIE INC. | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: OTEZLA, BREZTRI, Korlym, NEXLETOL, FARXIGA, UBRELVY, Ozempic, Auvelity.
Industry payments across SC — which companies pay providers there.
